Jaye Crowder
Psychiatry · Dallas, TXNPI 1841402476
Payments from drug & device makers
Across 281 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- AbbVie$908
- Bausch Health US, LLC$482
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$273
- Vanda Pharmaceuticals Inc.$222
- Otsuka America Pharmaceutical, Inc.$207
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,03799%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 71 | $1,237 |
| AbbVie(2 entities) | 57 | $908 |
| Bausch Health US, LLC | 33 | $482 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $273 |
| Vanda Pharmaceuticals Inc. | 9 | $222 |
| Otsuka America Pharmaceutical, Inc. | 9 | $207 |
| Neurocrine Biosciences, Inc. | 4 | $185 |
| Johnson & Johnson | 10 | $172 |
| Alkermes, Inc. | 7 | $129 |
| Supernus Pharmaceuticals, Inc. | 7 | $122 |
| Tris Pharma Inc | 7 | $116 |
| Shire North American Group Inc | 6 | $96 |
| Teva Pharmaceuticals USA, Inc. | 4 | $83 |
| Adlon Therapeutics L.p. | 5 | $78 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| Eisai Inc. | 3 | $76 |
| Idorsia Pharmaceuticals US Inc | 4 | $69 |
| Merck | 5 | $68 |
| Scilex Pharmaceuticals Inc. | 1 | $66 |
| Avanir Pharmaceuticals, Inc. | 4 | $64 |
| Noven Therapeutics, LLC | 3 | $56 |
| Almatica Pharma LLC | 3 | $54 |
| Corium, LLC | 2 | $49 |
| E.r. Squibb & Sons, L.L.C. | 2 | $44 |
| Validus Pharmaceuticals LLC | 1 | $42 |
| Alfasigma USA, Inc. | 2 | $34 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Tempus AI, Inc | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$129
How this compares
$5,084 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 67 | $34,615 |
| Abilify MaintenaAripiprazole | 13 | $31,814 |
| VyvanseLisdexamfetamine Dimesylate | 48 | $17,620 |
| Memantine Hcl | 47 | $9,872 |
| Lisdexamfetamine Dimesylate | 11 | $3,076 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 53 | $2,068 |
| Vilazodone Hcl | 15 | $1,195 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 14 | $995 |
| Quetiapine Fumarate | 27 | $754 |
| Bupropion XlBupropion Hcl | 48 | $733 |
| Methylphenidate Hcl | 25 | $646 |
| Clonazepam | 62 | $611 |
| Modafinil | 12 | $611 |
| Duloxetine Hcl | 74 | $566 |
| Aripiprazole | 33 | $550 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $1,237 | $52,235115 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $207 | $31,81413 claims |
| Almatica Pharma LLCSertraline Hcl | $54 | $27367 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Dallas
- Scott BartleyDallas$42.7M
- Darin OkudaDallas$14.7M
- Michael DowningDallas$7.6M
- John PascoeDallas$2.3M
- Madhukar TrivediDallas$2.1M
- Manish JhaDallas$1.3M
- Mary KnesevichDallas$1.2M
- Seema GuptaDallas$1.2M
- Eric WilliamsDallas$976K
- Joel HolinerDallas$948K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.